Carisma Therapeutics Presents Data at The American Association for Cancer Research Annual Meeting Thumbnail Image Read more about Carisma Therapeutics Presents Data at The American Association for Cancer Research Annual Meeting
Ryvu Therapeutics Presents Recent Data from Multiple Oncology Programs at AACR 2021 Thumbnail Image Read more about Ryvu Therapeutics Presents Recent Data from Multiple Oncology Programs at AACR 2021
Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13 Thumbnail Image Read more about Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13
Publication of CPX-351 Clinical Data in 'Blood Advances': Phase 3 Post-Hoc Analyses Thumbnail Image Read more about Publication of CPX-351 Clinical Data in 'Blood Advances': Phase 3 Post-Hoc Analyses
Carisma Therapeutics Completes Series B Financing Totaling $59 Million Thumbnail Image Read more about Carisma Therapeutics Completes Series B Financing Totaling $59 Million
Kymera Therapeutics Initiates Dosing in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader Thumbnail Image Read more about Kymera Therapeutics Initiates Dosing in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader
NexImmune Announces Closing of Upsized Initial Public Offering Thumbnail Image Read more about NexImmune Announces Closing of Upsized Initial Public Offering
Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline Thumbnail Image Read more about Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline
Immune-Onc Building Broad Pipeline of Myeloid Checkpoint Inhibitors Thumbnail Image Read more about Immune-Onc Building Broad Pipeline of Myeloid Checkpoint Inhibitors
Affimed Announces Continuation of REDIRECT, a Registration-directed Study of AFM13 in PTCL, after Positive Preplanned Interim Futility Analysis Thumbnail Image Read more about Affimed Announces Continuation of REDIRECT, a Registration-directed Study of AFM13 in PTCL, after Positive Preplanned Interim Futility Analysis
